Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Minerva Surgical, Inc. (UTRS)

0.0001
0.0000
(0.00%)
At close: May 2 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Darin Hammers Chief Executive Officer -- -- --
Mr. Greg Simbro Vice President of Finance -- -- --
Ms. Wendy Bowman Vice President of Human Resources -- -- --
Dr. Evgueni V. Skalnyi M.D. Chief Medical Officer 365.25k -- 1966
Mr. Brent Palmisano Chief Commercial Officer -- -- --
Ms. Joanne Long Vice President of Corporate Controller -- -- --

Minerva Surgical, Inc.

4255 Burton Drive
Santa Clara, CA 95054
United States
855 646 7874 https://minervasurgical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
174

Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Corporate Governance

Minerva Surgical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 10:59 AM UTC - February 24, 2025 at 12:00 PM UTC

Minerva Surgical, Inc. Earnings Date

Recent Events

January 4, 2024 at 12:00 AM UTC

15-12G: Notice of termination of registration of a class of securities under Section 12(g)

December 26, 2023 at 12:00 AM UTC

S-8 POS: Offering Registrations

December 15, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 13, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 2, 2023 at 12:00 AM UTC

SC 13E3/A: Tender Offer/Acquisition Reports

October 13, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 29, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 3, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 2, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 7, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers